Celsion Corp (NASDAQ:CLSN)

2.29
Delayed Data
As of Apr 20
 +0.01 / +0.44%
Today’s Change
1.24
Today|||52-Week Range
6.06
-14.55%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$42.4M

Company Description

Celsion Corp . engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Contact Information

Celsion Corp.
997 Lenox Drive
Lawrenceville New Jersey 08648
P:(609) 896-9100
Investor Relations:
(609) 482-2455

Employees

Shareholders

Mutual fund holders2.48%
Other institutional2.12%
Individual stakeholders0.48%

Top Executives

Michael H. TardugnoChairman, President & Chief Executive Officer
Jeffrey Wayne ChurchCFO, Secretary & SVP-Investor Relations
Nicholas BorysChief Medical Officer & Senior Vice President
Khursheed AnwerChief Scientific Officer & Executive VP
Jason G. FewellVice President-Preclinical Research